Back to search
Primary Generalized Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Epilepsy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Generalized Epilepsy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 admini…
The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenil…
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures
The primary goal of the study is to explore the neurocognitive, emotional-behavioral functioning, and quality of life of adolescents with IGE, identifying key f…
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.
52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)